Fundraising Fox

Anthony Melendez

Investor

Managing Director at AbbVie

New York, New York

Writes $100K – $5M checks · typically $1.5M

Experience

  1. BraidwellBiotech Investor2022 — 2025
  2. Bicara TherapeuticsBoard Observer2023 — 2024
  3. Tourmaline BioBoard Observer2023
  4. AbbVieAbbVie Ventures2021 — 2022
  5. AbbVieCorporate Strategy2019 — 2021
  6. Trishula Therapeutics, Inc.Board Observer2021 — 2022
  7. Nitrase TherapeuticsBoard Observer2021 — 2022
  8. Quanta TherapeuticsBoard Observer2021 — 2022
  9. Cowen Inc.Biotech Equity Research2018 — 2019Greater New York City Area
  10. Boston Consulting Group (BCG)Management Consultant2017 — 2018Greater New York City Area
  11. University of South FloridaResearch Associate, Medicinal Chemistry2009 — 2011
  12. UF Health and Tampa General HospitalRegistered Nurse, Surgical and Neurological Intensive Care Unit / Cardiac Admit Unit2006 — 2011

Education

  1. Harvard Business SchoolMBA
  2. Icahn School of Medicine at Mount SinaiMD
  3. University of FloridaBA

Colleagues at AbbVie

Anke Reichardt
Investor at AbbVie
Christian Schubert
Head of AbbVie Ventures at AbbVie
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
John Gustofson
Managing Director at AbbVie

Frequently asked questions

Where does Anthony Melendez work?
Anthony Melendez is Managing Director at AbbVie.
What check size does Anthony Melendez write?
Anthony Melendez typically writes checks of $100K – $5M.

Same school

Also attended Harvard Business School1,969

Brad GerstnerFounder & CEO of Altimeter Capital; architect of Invest America; BG2 co-hostAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins

+ 1,963 more

Also attended Icahn School of Medicine at Mount Sinai16

Justin RobenyAssociate at Osage University PartnersOmar Njie, MDPrincipal at AlleyCorpVinod MittaVenture Partner at Floating PointTara BishopInvestor at Black Opal VenturesScott GottliebPartner at New Enterprise Associates (NEA)Sharon HuangAssociate at Tau Ventures

+ 10 more

Also attended University of Florida139

Bill GurleyGeneral Partner Emeritus at Benchmark; author of Above the Crowd; BG2 co-hostLauren HolsingerChief Of Staff at March Capital PartnersAndrea EchstenkamperVP of Marketing at HeavybitAmy KalokerinosInvestor at Khosla VenturesBrendon SchmidtPrincipal & Head of Business Development at Sierra VenturesDavid CorreaChief Financial Officer and Chief Compliance Officer at Marlin Equity Partners

+ 133 more

Shared employers

Also worked at Bicara Therapeutics4

Jon EdwardsGeneral Partner at ForbionHeath LukatchPartner at Novo HoldingsMichelle DoigPartner at Omega FundsKrishna PoluPrincipal at Red Tree Venture

Also worked at AbbVie40

Nick GasbarroChief of Staff at QED InvestorsManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next VenturesAndrew BierDigital Pharma Advisor at Excelerate Health VenturesShwen GweeDigital Pharma Advisor at Excelerate Health Ventures

+ 34 more

Also worked at Nitrase Therapeutics7

Henrijette RichterManaging Partner at Sofinnova PartnersRobert BlazejPartner at Mission Bay CapitalAnta GkelouPartner, Capital Strategy at Sofinnova PartnersMargarita ChavezManaging Director at AbbVieShawna FrazierDirector at AbbVieJonathan BehrPartner at SV Health Investors

+ 1 more

Also worked at Cowen Inc.52

Michael McBrideInvestor at GV (Google Ventures)Robert SeveroPartner, Chief Compliance Officer at Sapphire VenturesPeter ChungManaging Director at Marlin Equity PartnersMeir UkelesInvestor at Israel Cleantech VenturesEmily PawlakVice President at Volition CapitalAvinash KantInvestor at Phoenix Venture Partners

+ 46 more